Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis

PDW Kirk, A Witkover, A Courtney, AM Lewin, R Wait… - Retrovirology, 2011 - Springer
Background Human T lymphotropic virus Type 1 (HTLV-1) causes a chronic inflammatory
disease of the central nervous system known as HTLV-1-associated myelopathy/tropical …

Lessons from the cerebrospinal fluid analysis of HTLV-1-infected individuals: biomarkers of inflammation for HAM/TSP development

NL Freitas, YCP Gomes, FS Souza, RC Torres… - Viruses, 2022 - mdpi.com
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a
neurodegenerative disease that leads to motor impairment due to a chronic inflammatory …

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Y Enose-Akahata, S Jacobson - Retrovirology, 2019 - Springer
Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately
10–20 million people worldwide. While the majority of infected people are asymptomatic …

CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis

T Sato, A Coler-Reilly, A Utsunomiya… - PLoS neglected …, 2013 - journals.plos.org
Background Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is a rare chronic neuroinflammatory disease. Since the …

Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation

T Assone, SM Menezes, F de Toledo Gonçalves… - Journal of …, 2022 - Springer
Abstract Background HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
(HAM/TSP) is an incapacitating neuroinflammatory disorder for which no disease-modifying …

Following the clues: usefulness of biomarkers of neuroinflammation and neurodegeneration in the investigation of HTLV-1-associated myelopathy progression

FS Souza, NL Freitas, YCP Gomes, RC Torres… - Frontiers in …, 2021 - frontiersin.org
Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a neurodegenerative disease due to axonal damage of the …

Proposal of classification criteria for HTLV-1-associated myelopathy/tropical spastic paraparesis disease activity

T Sato, N Yagishita, K Tamaki, E Inoue… - Frontiers in …, 2018 - frontiersin.org
Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare chronic neuroinflammatory disease. While the disease …

[HTML][HTML] HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression

E Matsuura, S Nozuma, Y Tashiro, R Kubota… - Journal of the …, 2016 - Elsevier
Abstract Objective HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
can progress slowly or rapidly even though a set of symptoms such as spastic paraparesis …

Proviral load and the balance of serum cytocines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

ALB Starling, OA Martins-Filho, JR Lambertucci… - Acta tropica, 2013 - Elsevier
This study compared the proviral load and the plasma cytokine profiles (interleukin-IL-2, IL-
4, IL-6, IL-10, TNF-α, IFN-γ) in 87 HTLV-1-infected individuals, including 28 with HTLV-1 …

Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic …

ML Martins, JC Guimarães, JG Ribas… - Journal of …, 2017 - Springer
Abstract HTLV-1 proviral load (pvl) is an important risk marker for HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP), but its value as prognostic marker is not …